Search research articles
Contact Us
Filters
Showing results (151-160 of 167) with videos related to
Page
of 17
Sort By:
Nature
|
November 26, 2010
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
Cory M Johannessen, Jesse S Boehm, So Young Kim, et al.
Cell Systems
|
August 25, 2017
Decomposing Oncogenic Transcriptional Signatures to Generate Maps of Divergent Cellular States
Jong Wook Kim, Omar O Abudayyeh, Huwate Yeerna, et al.
Cell Systems
|
October 10, 2017
A Community Challenge for Inferring Genetic Predictors of Gene Essentialities through Analysis of a Functional Screen of Cancer Cell Lines
Mehmet Gönen, Barbara A Weir, Glenn S Cowley, et al.
Nature Biotechnology
|
April 23, 2014
Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer
Jens G Lohr, Viktor A Adalsteinsson, Kristian Cibulskis, et al.
Nature Cancer
|
July 3, 2020
Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling
Steven M Corsello, Rohith T Nagari, Ryan D Spangler, et al.
Scientific Data
|
May 19, 2015
Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies
Glenn S Cowley, Barbara A Weir, Francisca Vazquez, et al.
Nature Biotechnology
|
September 11, 2010
Towards patient-based cancer therapeutics
, Stuart L Schreiber, Alykhan F Shamji, et al.
Nature
|
April 12, 2019
WRN helicase is a synthetic lethal target in microsatellite unstable cancers
Edmond M Chan, Tsukasa Shibue, James M McFarland, et al.
Communications Biology
|
April 8, 2024
Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin
Karuna Mittal, Garrett W Cooper, Benjamin P Lee, et al.
Elife
|
March 13, 2019
Renal medullary carcinomas depend upon <i>SMARCB1</i> loss and are sensitive to proteasome inhibition
Andrew L Hong, Yuen-Yi Tseng, Jeremiah A Wala, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 167) with videos related to
Sort By:
Page
of 17
Nature
|
November 26, 2010
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
Cory M Johannessen, Jesse S Boehm, So Young Kim, et al.
Cell Systems
|
August 25, 2017
Decomposing Oncogenic Transcriptional Signatures to Generate Maps of Divergent Cellular States
Jong Wook Kim, Omar O Abudayyeh, Huwate Yeerna, et al.
Cell Systems
|
October 10, 2017
A Community Challenge for Inferring Genetic Predictors of Gene Essentialities through Analysis of a Functional Screen of Cancer Cell Lines
Mehmet Gönen, Barbara A Weir, Glenn S Cowley, et al.
Nature Biotechnology
|
April 23, 2014
Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer
Jens G Lohr, Viktor A Adalsteinsson, Kristian Cibulskis, et al.
Nature Cancer
|
July 3, 2020
Discovering the anti-cancer potential of non-oncology drugs by systematic viability profiling
Steven M Corsello, Rohith T Nagari, Ryan D Spangler, et al.
Scientific Data
|
May 19, 2015
Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies
Glenn S Cowley, Barbara A Weir, Francisca Vazquez, et al.
Nature Biotechnology
|
September 11, 2010
Towards patient-based cancer therapeutics
, Stuart L Schreiber, Alykhan F Shamji, et al.
Nature
|
April 12, 2019
WRN helicase is a synthetic lethal target in microsatellite unstable cancers
Edmond M Chan, Tsukasa Shibue, James M McFarland, et al.
Communications Biology
|
April 8, 2024
Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicin
Karuna Mittal, Garrett W Cooper, Benjamin P Lee, et al.
Elife
|
March 13, 2019
Renal medullary carcinomas depend upon <i>SMARCB1</i> loss and are sensitive to proteasome inhibition
Andrew L Hong, Yuen-Yi Tseng, Jeremiah A Wala, et al.
Page
of 17